Akari Therapeutics plc ADS (AKTX)
NASDAQ: AKTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 1:13 PM ET
AKTX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $19.38M
- EPS (TTM)
- $0.00
- Dividend yield
- None
- 52-week range
- 3.02 – 42.80
- Day range
- 8.35 – 8.73
- Volume / Avg
- 45.58K / 60.35K
- Beta
- —
- Shares outstanding
- 2.29M
52-week range
AKTX stock today
Shares of Akari Therapeutics (AKTX) are trading lower on Oct 8 at $8.48, a drop of 1.68% or $0.145 per share, versus the S&P 500's 0.71% decline. At this level, AKTX sits near the bottom of its 52-week range of $3.02 to $42.80: 80.2% below the high and 181.3% above the low. AKTX is down 25.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 79.5%.
Akari Therapeutics has posted a net loss over the last twelve months (EPS of $0.00), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Akari Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Tampa, FL
Akari Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares | 3.14 | -0.16% | $20.19M | vs AKTX |
| COCPCocrystal Pharma Inc. | 1.06 | -0.91% | $20.42M | vs AKTX |
| NEUPNeuphoria Therapeutics Inc. | 3.38 | -1.22% | $18.28M | vs AKTX |
| UPCUniverse Pharmaceuticals Inc. Class A | 4.26 | -3.30% | $21.38M | vs AKTX |
| ACTUActuate Therapeutics Inc. | 0.7241 | -0.01% | $17.39M | vs AKTX |
| QNRXQuoin Pharmaceuticals Ltd. ADR | 4.63 | -1.49% | $22.24M | vs AKTX |
| NCELNewcelX Ltd. | 2.95 | -2.97% | $17.01M | vs AKTX |
| AYTUAytu BioPharma Inc. | 2.08 | +1.22% | $22.55M | vs AKTX |
Indexes, lists and sector
Akari Therapeutics stock FAQ
What is Akari Therapeutics's stock price today?
AKTX last traded at $8.48 as of Oct 8, 1:13 PM EDT, down 1.68% on the day. Prices are delayed at least 15 minutes.
Does Akari Therapeutics pay a dividend?
No. Akari Therapeutics does not currently pay a regular cash dividend.
Has AKTX ever split its stock?
Yes. The most recent AKTX stock split was a 1-for-40 split on Mar 31, 2026, one of 3 splits on record.
What is the AKTX 52-week high?
The 52-week high for AKTX is $42.80 and the 52-week low is $3.02. The stock is currently 80.2% below its high.